|
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors Clinical research trials and Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors. Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors clinical trial. Subjects frequently obtain the most expert healthcare possible for their Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors  Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
For Condition: Carotid Atherosclerosis,Myocardial Infarction
Status: Completed
Sponsor(s): Warren G Magnuson Clinical Center (CC) ,
Synopsis: Iron has been proposed to contribute to atherogenesis in humans by facilitating the oxidation of lipoproteins. This observational study will evaluate the association between frequency of blood donation - expected to be associated with relatively reduced body iron stores in frequent donors - and carotid atherosclerosis. The primary outcome variable will be whether the presence and extent of asymptomatic carotid atherosclerosis as measured by ultrasound is greater in infrequent (less than or equal to 1 donations/year greater than or equal to 5 years) vs. frequent (greater than or equal to 4 donations/year greater than or equal to 5 years) blood donors. Body iron stores, lipid and hemostatic parameters, nitric oxide formation, inflammatory parameters, and markers of vascular oxidative stress will be analyzed as secondary outcome measures. Laboratory analysis and ultrasound testing will be performed blinded to the patient's phlebotomy and iron status. Sixty frequent (n=40 males greater than 40 y/o, n=20 females greater than 50 y/o) and 60 infrequent (n=40 males greater than 40 y/o, n=20 females greater than 50 y/o) blood donors will be recruited for this study from the Department of Transfusion Medicine, W. G. Magnuson Clinical Center. All donors will be assessed for study eligibility and cardiovascular risks during the screening visit. The presence of atherosclerotic lesions by carotid ultrasound and secondary outcome parameters will be assessed during a second visit.
Details: Iron has been proposed to contribute to atherogenesis in humans by facilitating the oxidation of lipoproteins. This observational study will evaluate the association between frequency of blood donation - expected to be associated with relatively reduced body iron stores in frequent donors - and carotid atherosclerosis. The primary outcome variable will be whether the presence and extent of asymptomatic carotid atherosclerosis as measured by ultrasound is greater in infrequent (less than or equal to 1 donations/year greater than or equal to 5 years) vs. frequent (greater than or equal to 4 donations/year greater than or equal to 5 years) blood donors. Body iron stores, lipid and hemostatic parameters, nitric oxide formation, inflammatory parameters, and markers of vascular oxidative stress will be analyzed as secondary outcome measures. Laboratory analysis and ultrasound testing will be performed blinded to the patient's phlebotomy and iron status. Sixty frequent (n=40 males greater than 40 y/o, n=20 females greater than 50 y/o) and 60 infrequent (n=40 males greater than 40 y/o, n=20 females greater than 50 y/o) blood donors will be recruited for this study from the Department of Transfusion Medicine, W. G. Magnuson Clinical Center. All donors will be assessed for study eligibility and cardiovascular risks during the screening visit. The presence of atherosclerotic lesions by carotid ultrasound and secondary outcome parameters will be assessed during a second visit.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Age greater than or equal to 40 years for males and greater than or equal to 50 years for females. Standard eligibility criteria for blood donation, per guidelines established by the Food and Drug Administration and the American Association of Blood Banks. Ability to provide consent after full information is provided. EXCLUSION CRITERIA: Pregnancy or lactation. Patients with clinically significant dementia or psychiatric disturbances, including alcohol and substance abuse. Presence of the following American Heart Association cardiovascular risks: diabetes mellitus, hypertension (systolic greater than 140 mmHg, diastolic greater than 90 mmHg), smoking (greater than 10 cigarettes/day), high density lipoprotein cholesterol less than 35 mg/dL, hyperlipidemia (total cholesterol greater than 240 mg/dL), family history of premature coronary heart disease. Anticoagulant, thrombolytic, hemorrheologic and/or antiplatelet agents (within the last 10 days). Any other condition or therapy which in the opinion of the investigators may pose a risk to the patient or confound the results of the study.
Total Enrollment: 120
Location and Contact Information:
Warren G. Magnuson Clinical Center (CC)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 970113; 97-CC-0113
Study Start Date: April 28, 1997
Record last reviewed: May 2, 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001589
Other Carotid Atherosclerosis Studies:
1. Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
2. Potential Risk Factors for Stroke
Related Studies:
Other Carotid Atherosclerosis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
|
|
|
|
|
|
|
|
